Table 1: Description of the Sample.
Total Sample (n=363) | Stroke (n=113) | No Stroke (n=250) | |
---|---|---|---|
Demographics | |||
Non-Caucasian (n, %)*** | 92 (25.3%) | 42 (37.2%) | 50 (20.0%) |
Female (n, %) | 149 (41.0%) | 51 (45.1%) | 98 (39.2%) |
Age (mean, SD)*** | 62.8 (6.4) | 64.6 (6.8) | 62.0 (6.0) |
Clinical Characteristics (Baseline) | |||
Weight in Kg (mean, SD)*** | 91.7 (17.4) | 88.0 (18.4) | 93.3 (16.7) |
BMI (mean, SD) | 31.9 (5.1) | 31.3 (5.5) | 31.2 (4.9) |
Systolic BP (mean, SD)*** | 137.3 (18.0) | 144.5 (17.8) | 134.0 (17.1) |
Years of hypertension (mean, SD) | 10.2 (9.5) | 10.7 (9.5) | 9.9 (9.5) |
Years of diabetes (mean, SD) | 10.7 (7.4) | 11.7 (7.7) | 10.2 (7.2) |
Hemoglobin A1C (mean, SD)* | 8.5 (0.9) | 8.7 (1.0) | 8.4 (0.8) |
Smoke (n, %) | 40 (11.0%) | 11 (9.7%) | 29 (11.6%) |
Cardiovascular disease history (n, %) | 124 (34.2%) | 39 (34.5%) | 85 (34.0%) |
Left Ventricular Hypertrophy (n, %) | 5 (1.4%) | 4 (3.5%) | 1 (0.4%) |
On Hypertensive Medication (n, %) | 300 (82.6%) | 98 (86.7%) | 202 (80.8%) |
Atrial Fibrillation (n, %) | 3 (0.8%) | 1 (0.9%) | 2 (0.8%) |
Framingham Score (mean, SD)*** | 9.3 (2.9) | 10.4 (2.7) | 8.8 (2.9) |
GFR<60ml/min/1.73m2 (n, %) | 36 (9.9%) | 15 (13.4%) | 21 (8.4%) |
Total cholesterol (mean, SD)* | 184.5 (43.2) | 192.2 (46.0) | 181.1 (41.6) |
High density lipoprotein (mean, SD) | 41.9 (12.4) | 43.4 (15.1) | 41.2 (10.9) |
Low density lipoprotein (mean, SD) | 105.2 (33.7) | 110.4 (32.6) | 102.9 (34.0) |
Triglycerides (mean, SD) | 192.5 (130.2) | 198.8 (166.2) | 189.7 (110.5) |
Years of hyperlipidemia (mean, SD) | 6.6 (6.0) | 7.2 (6.7) | 6.3 (5.7) |
Neurofilament light chain (median, IQR) | 15.2 (11.0, 22.8) | 19.8 (14.7, 30.9) | 13.8 (9.9, 19.6) |
SD = standard deviation
p < 0.001
p < 0.05